We could not find any results for:
Make sure your spelling is correct or try broadening your search.
In the United States, a new drug application, or NDA, is the vehicle through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing. And news that...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - L'OCRI...
Canadian Investment Regulatory Organization Trading Halt - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: Medexus...
L'Organisme canadien de réglementation des investissements permet la reprise de la négociation - MDP Canada NewsWire TORONTO, le 6 juin 2024 TORONTO, le 6 juin 2024 /CNW/ - Reprise...
Canadian Investment Regulatory Organization Trade Resumption - MDP Canada NewsWire TORONTO, June 6, 2024 TORONTO, June 6, 2024 /CNW/ - Trading resumes in: Company: Medexus Pharmaceuticals...
Suspension de la négociation par l'Organisme canadien de réglementation des investissements - MDP.DB Canada NewsWire TORONTO, le 16 oct. 2023 TORONTO, le 16 oct. 2023 /CNW/...
Canadian Investment Regulatory Organization Trading Halt - MDP.DB Canada NewsWire TORONTO, Oct. 16, 2023 TORONTO, Oct. 16, 2023 /CNW/ - The following issues have been halted by CIRO: Company:...
TORONTO and CHICAGO, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF), is pleased to announce that it has entered into an...
TORONTO and CHICAGO, April 18, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce that company management will be participating in the 2023 Bloom...
TORONTO and CHICAGO, April 11, 2023 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals (TSX: MDP; OTCQX: MEDXF) is pleased to announce preliminary revenue estimates for the company’s fourth fiscal...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.06 | 2.44897959184 | 2.45 | 2.63 | 2.39 | 25706 | 2.5577526 | CS |
4 | 0.03 | 1.20967741935 | 2.48 | 2.75 | 2.12 | 28044 | 2.52160147 | CS |
12 | 0.68 | 37.1584699454 | 1.83 | 2.75 | 1.82 | 33456 | 2.37095636 | CS |
26 | 0.95 | 60.8974358974 | 1.56 | 2.75 | 1.47 | 40149 | 1.92538893 | CS |
52 | -0.59 | -19.0322580645 | 3.1 | 3.39 | 1.44 | 46930 | 1.99097874 | CS |
156 | -0.49 | -16.3333333333 | 3 | 3.83 | 0.88 | 37231 | 2.10172492 | CS |
260 | -4.87 | -65.9891598916 | 7.38 | 7.9 | 0.88 | 39253 | 2.40020974 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions